Joseph R Stein, DO | |
One Medical Center Dr, Lebanon, NH 03756-0001 | |
(603) 650-7650 | |
Not Available |
Full Name | Joseph R Stein |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 9 Years |
Location | One Medical Center Dr, Lebanon, New Hampshire |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1477940070 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
Graham Hospital Association | Canton, IL | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Dartmouth-hitchcock Clinic | 4183537509 | 1139 |
Mary Hitchcock Memorial Hospital | 4486561164 | 964 |
Graham Hospital Association | 2769375021 | 90 |
News Archive
In the first half of 2009 Bavarian Nordic generated revenue of DKK 33 million and recorded a loss before tax of DKK 188 million. As of 30 June 2009 the Group's net free liquidity was DKK 489 million.
An atomic-level snapshot of a respiratory syncytial virus (RSV) protein bound to a human antibody represents a leap toward developing a vaccine for a common-and sometimes very serious-childhood disease.
IDC has released a new special research study on the market for employee benefits administration in the U.S., which shows that over 70% of all employers - both small and large - are either concerned or very concerned over the ramifications of potential healthcare reform legislation. While concerned with the as-yet-undetermined changes in legislation, the rising costs of providing employees with health and welfare benefits is even more of a concern to buyers, with over 80% reporting it as the top challenge they face.
A new, noninvasive nuclear medicine test can be used to determine whether aromatase inhibitor treatment will be effective for specific cancer patients, according to a recent study reported in The Journal of Nuclear Medicine.
Understanding the body's immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.
› Verified 1 days ago
Entity Name | Mary Hitchcock Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023092053 PECOS PAC ID: 4486561164 Enrollment ID: O20031126000258 |
News Archive
In the first half of 2009 Bavarian Nordic generated revenue of DKK 33 million and recorded a loss before tax of DKK 188 million. As of 30 June 2009 the Group's net free liquidity was DKK 489 million.
An atomic-level snapshot of a respiratory syncytial virus (RSV) protein bound to a human antibody represents a leap toward developing a vaccine for a common-and sometimes very serious-childhood disease.
IDC has released a new special research study on the market for employee benefits administration in the U.S., which shows that over 70% of all employers - both small and large - are either concerned or very concerned over the ramifications of potential healthcare reform legislation. While concerned with the as-yet-undetermined changes in legislation, the rising costs of providing employees with health and welfare benefits is even more of a concern to buyers, with over 80% reporting it as the top challenge they face.
A new, noninvasive nuclear medicine test can be used to determine whether aromatase inhibitor treatment will be effective for specific cancer patients, according to a recent study reported in The Journal of Nuclear Medicine.
Understanding the body's immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.
› Verified 1 days ago
Entity Name | Dartmouth-hitchcock Clinic |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
In the first half of 2009 Bavarian Nordic generated revenue of DKK 33 million and recorded a loss before tax of DKK 188 million. As of 30 June 2009 the Group's net free liquidity was DKK 489 million.
An atomic-level snapshot of a respiratory syncytial virus (RSV) protein bound to a human antibody represents a leap toward developing a vaccine for a common-and sometimes very serious-childhood disease.
IDC has released a new special research study on the market for employee benefits administration in the U.S., which shows that over 70% of all employers - both small and large - are either concerned or very concerned over the ramifications of potential healthcare reform legislation. While concerned with the as-yet-undetermined changes in legislation, the rising costs of providing employees with health and welfare benefits is even more of a concern to buyers, with over 80% reporting it as the top challenge they face.
A new, noninvasive nuclear medicine test can be used to determine whether aromatase inhibitor treatment will be effective for specific cancer patients, according to a recent study reported in The Journal of Nuclear Medicine.
Understanding the body's immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Joseph R Stein, DO One Medical Center Dr, Lebanon, NH 03756-0001 Ph: (603) 650-7650 | Joseph R Stein, DO One Medical Center Dr, Lebanon, NH 03756-0001 Ph: (603) 650-7650 |
News Archive
In the first half of 2009 Bavarian Nordic generated revenue of DKK 33 million and recorded a loss before tax of DKK 188 million. As of 30 June 2009 the Group's net free liquidity was DKK 489 million.
An atomic-level snapshot of a respiratory syncytial virus (RSV) protein bound to a human antibody represents a leap toward developing a vaccine for a common-and sometimes very serious-childhood disease.
IDC has released a new special research study on the market for employee benefits administration in the U.S., which shows that over 70% of all employers - both small and large - are either concerned or very concerned over the ramifications of potential healthcare reform legislation. While concerned with the as-yet-undetermined changes in legislation, the rising costs of providing employees with health and welfare benefits is even more of a concern to buyers, with over 80% reporting it as the top challenge they face.
A new, noninvasive nuclear medicine test can be used to determine whether aromatase inhibitor treatment will be effective for specific cancer patients, according to a recent study reported in The Journal of Nuclear Medicine.
Understanding the body's immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.
› Verified 1 days ago
Thomas Ray Burdick, Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
William B. Zucconi, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-5000 | |
Dr. Thomas Francis Delaney, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-6600 | |
Dr. Jessica Margaret Sin, M.D., PH.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Dr, Lebanon, NH 03756 Phone: 603-650-7650 | |
Dr. Harlan G Herr, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-7650 | |
Matthew E Maeder, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Lebanon, NH 03756 Phone: 603-650-4371 | |
Dr. Judith Austin-strohbehn, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Department Of Radiology, Lebanon, NH 03756 Phone: 603-650-4477 Fax: 603-650-5455 |